Fundraising Fox
Cube Biotech
Founded 2012 · 59 employees on LinkedIn · 2 known investors
Find your way into Cube Biotech
Sign up to see every warm intro you have to Cube Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cube Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cube Biotech develops the NativeMP™ platform, including Cubipol/SMALP copolymers and active full-length membrane protein targets, for isolating, purifying, and studying membrane proteins such as ion channels. It also offers custom protein services and bead functionalization used by research institutions for applications like antibody generation and Cryo-EM structural analysis.
Investors · 2
Frequently asked questions
- What does Cube Biotech do?
- Cube Biotech develops the NativeMP™ platform, including Cubipol/SMALP copolymers and active full-length membrane protein targets, for isolating, purifying, and studying membrane proteins such as ion channels. It also offers custom protein services and bead functionalization used by research institutions for applications like antibody generation and Cryo-EM structural analysis.
- Who are Cube Biotech's investors?
- Cube Biotech's investors include ARCHIMED Japan, Creathor Ventures.